Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma
Open Access
- 5 April 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37646-37656
Abstract
Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinomaKeywords
This publication has 46 references indexed in Scilit:
- Folate Receptor α Associated With Triple-Negative Breast Cancer and Poor PrognosisArchives of Pathology & Laboratory Medicine, 2014
- Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian CancerInternational Journal of Molecular Sciences, 2013
- Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer TreatmentPLOS ONE, 2013
- Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2013
- Nuclear localization of folate receptor alpha: a new role as a transcription factorScientific Reports, 2012
- High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and MutationJournal of Thoracic Oncology, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 2010
- Pancreatic CancerNew England Journal of Medicine, 2010
- Genes involved with folate uptake and distribution and their association with colorectal cancer riskCancer Causes & Control, 2009